Brain Stimulation + Cognitive Training for Lyme Disease
What You Need to Know Before You Apply
What is the purpose of this trial?
This trial explores a new method to assist individuals with ongoing memory and thinking problems after Lyme disease treatment. The study combines brain stimulation, specifically Transcranial Direct Current Stimulation (tDCS), with engaging computer games designed to enhance brain processing speed. Participants will perform these activities at home for four weeks, with researchers later assessing whether any improvements persist. Individuals who have had Lyme disease, completed at least two rounds of antibiotics, and continue to experience cognitive issues affecting daily life may be suitable for this study. As an unphased trial, this study provides a unique opportunity to contribute to innovative research that could improve cognitive recovery for Lyme disease patients.
Do I need to stop taking my current medications for the trial?
You may need to stop taking certain medications. Participants must be off antibiotic treatment for tick-borne disease for at least 4 weeks before the study and during the 12-week study. You should not start new medications that might affect the treatment outcome unless medically necessary, and you must inform the study staff about any medication changes.
What prior data suggests that this brain stimulation and cognitive training approach is safe for individuals with Lyme disease?
Previous studies have shown that cognitive training helps people think and react faster. The BrainHQ program used in this trial builds on these studies and aims to improve brain function.
Transcranial direct current stimulation (tDCS) uses a mild electrical current applied to the head to enhance brain function. Research shows it is non-invasive, generally well-tolerated, and may help with mood, fatigue, and pain, common in people with long-term Lyme disease symptoms.
Both treatments have been used safely in different settings, and studies have not reported any serious side effects. This makes them promising options for further exploration in helping those with ongoing Lyme disease symptoms.12345Why are researchers excited about this trial's treatments?
Researchers are excited about these treatments because they combine cognitive training with Transcranial Direct Current Stimulation (tDCS), offering a novel approach for addressing cognitive issues associated with Lyme disease. Unlike typical medications that target symptoms through pharmaceuticals, tDCS uses a gentle electrical current to potentially enhance brain function. This non-invasive technique can be administered at home, making it convenient and accessible. Additionally, the cognitive tasks through BrainHQ are tailored to improve processing speed, which could lead to better cognitive outcomes for patients. This combination of brain stimulation and cognitive exercises represents a fresh, promising strategy distinct from conventional drug treatments.
What evidence suggests that this trial's treatments could be effective for cognitive symptoms in Lyme disease?
Research has shown that brain exercises can enhance cognitive speed. The BrainHQ program, used in this trial, has proven successful with other groups. Users often experience clearer thinking and quicker responses.
Additionally, studies have found that transcranial direct current stimulation (tDCS) can alleviate cognitive issues. It has reduced symptoms like depression and fatigue in other conditions. In this trial, some participants will receive active tDCS combined with brain exercises, potentially boosting brain function, while others will receive sham tDCS for comparison.12356Who Is on the Research Team?
Felicia C Chow, MD, MAS
Principal Investigator
University of California, San Francisco
Are You a Good Fit for This Trial?
This trial is for individuals who have cognitive symptoms after being treated for Lyme disease, known as Post Treatment Lyme Disease (PTLD). Participants will engage in at-home cognitive training with either real or sham brain stimulation over a period of 4 weeks.Inclusion Criteria
Exclusion Criteria
Timeline for a Trial Participant
Screening
Participants are screened for eligibility to participate in the trial
Treatment
Participants receive either active or sham transcranial direct current stimulation (tDCS) combined with computer-based cognitive training at home for 4 weeks
Follow-up
Participants are monitored for sustained treatment benefits in processing speed and other cognitive functions
What Are the Treatments Tested in This Trial?
Interventions
- Cognitive training
- Transcranial Direct Current Stimulation (tDCS)
Find a Clinic Near You
Who Is Running the Clinical Trial?
University of California, San Francisco
Lead Sponsor
Bay Area Lyme Foundation
Collaborator